Therefore, in this study, we investigated the frequency of LDLR-Ava II and APOB-Xba I polymorphisms in patients with severe hypercholesterolemia not suffering from any secondary cause, as well as a group of normocholesterolemia subjects. This evidence concerns the gene APOB and familial hypercholesterolemia.